Efficacy and Safety of Functional Neurogenesis Stimulation Therapy in Children With Autism Spectrum Disorder (ASD)
Clinical trial NCT07276555 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07276555
- Sponsor
- Neurocytonix, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2029-02-01
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.